TechPharmaNet – Brazil 2025
This networking conference showcases cutting-edge technologies for the production of more and better medicines in Brazil, bringing together high-level executives, industry innovators, and regulatory experts. With dynamic presentations, panels, and networking sessions, the event explores advancements in nanotechnology, purification systems, and big data analytics. Discussions will highlight their transformative impact on production efficiency, sustainability, and patient safety, solidifying Brazil’s position as a hub for pharmaceutical innovation.
Key Objectives:
– Examine advancements in nanotechnology for targeted drug delivery and their impact on treating complex diseases with minimized side effects.
– Highlight cutting-edge purification technologies improving quality and efficiency in pharmaceutical manufacturing.
– Explore the role of big data analytics in optimizing production processes, reducing waste, and enhancing resource utilization.
– Discuss how machine learning improves pharmacovigilance by enabling early detection of adverse drug reactions and enhancing safety monitoring.
Who will
you meet?
More than:
Participants
Companies
VPs
GMs
Heads
Directors
Managers
Specialists
Chief Data Officers
From these areas:
- R&D
- Pre-clinical Development
- Design
- Manufacturing
- Clinical Development
- Quality Control
- Quality Assurance
- Production
- Commercial
- Facility
- Engineering
- Marketing
Plan Your 1-to-1 Meetings with JackLeckerman App
Speaker Board 2024
Leticia Pérez Becerra
Government Director
Angel Alvarado
New Business Representative
Raul Rogelio Trejo Rosales
Assigned Doctor
Ivonne Perez Cruz
National Channel Sales Manager
Allan Mauricio Marruffo Carmona
Formulation Chemist
Omar Genaro López Navarro
Medical Lead Latin America North
Alejandra Cruz Salinas
Innovation Manager
Luis Enrique Reynoso Rojas
Head of Biotechnology
Antonino Di Bartolo
Director of Sales And Business Development - Americas
Luis Felipe Reyes Fuentes
Former Medical Affaires Head Oncology
Judith Pasaflores
Sales Director
Paul Rojas Luna
Director of Operations and Compliance
Araceli Pérez García
Director of New Business and Portfolio Strategy
Luis Enrique Estevez Cruz
President
Edgar Vazquez Ramos
Field Application Scientist
Mario Novoa Belman
Sales & Application Specialist
Virgilio Garcia
LATAM West General Manager
Alexander Schäfer
Business Development Manager
Deyanira Chiñas Ramirez
Commercial Director
Nestor Perez
COO and R&D Director
Sonia Mayra Pérez Tapia
Executive Director
Philippe Lauwers
Technology Development Director
Program at a Glance
Cybersecurity in Pharmaceutical Systems
This session will present critical data and strategies to enhance the cybersecurity of pharmaceutical systems. It will highlight current threats, protective measures, and innovative approaches to safeguarding sensitive data and operational integrity
Artificial Intelligence in Drug Discovery: Accelerating Innovation in Pharma
Nanotechnology in Drug Delivery
This panel will examine the transformative role of nanotechnology in pharmaceutical development. Experts will discuss advancements in targeted drug delivery systems, their potential to minimize side effects, and their impact on the efficiency of treatment for complex diseases.
Purification Technology for Pharmaceutical Manufacturing
This session will present critical data and strategies to enhance the cybersecurity of pharmaceutical systems. It will highlight current threats, protective measures, and innovative approaches to safeguarding sensitive data and operational integrity.
How Big data can improve Medicine production
This panel will explore how big data analytics is transforming pharmaceutical manufacturing. Speakers will discuss the integration of data-driven insights into production processes, improving yield, reducing waste, and optimizing resource utilization.
Full Programme in the PDF Agenda
Download Agenda
Sponsors
Media Partners
Photo Gallery from Previous Events
Testimonials
-
”It was an excellent opportunity to hear what the authorities industry, even sometimes what our competitors or other providers have to say about the topic.”
Alison Bascou, Sr. Regulatory Director at BD, France
-
"I think it's being an interesting event. Wherever there's discussion at top level, wherever there's respect. wherever there's an open forum, science can advance. It's very important to keep patient's well-being in mind and I think this forum allows that."
Jaime Uribe, CEO At PROBIOMED
-
“The strength of the biosimilar industry in our region is very encouraging. It seems to me this event is the propitious forum to share experiences and it is great.”
Tammy Boggiano Ayo, Process Development Director at CIM, Cuba
-
“It showed a broad picture, from a highly technical perspective up to a commercial viewpoint. It is not easy to get that in such a short period of time.”
Santiago Salguero, Executive Director at Pharmaceutical Association of Ecuador
-
“For companies like those I work for, i.e. suppliers to the pharmaceutical industry, this has been a great opportunity to see our clients’ perspective and above all to identify the major trends determining the future of biosimilars.”
Mauricio Roberto Hernández Morales, Key Account and Business Developer Manager at BD Mexico